Comparative efficacy and safety of golimumab, infliximab and adalimumab for the treatment of moderate to severe ulcerative colitis- A bayesian indirect treatment comparison meta-analysis
May 1, 2014, 00:00
10.1016/j.jval.2014.03.213
https://www.valueinhealthjournal.com/article/S1098-3015(14)00264-2/fulltext
Title :
Comparative efficacy and safety of golimumab, infliximab and adalimumab for the treatment of moderate to severe ulcerative colitis- A bayesian indirect treatment comparison meta-analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00264-2&doi=10.1016/j.jval.2014.03.213
First page :
A35
Section Title :
Gastrointestinal Disorders
Open access? :
No
Section Order :
1249